Harvard Bioscience (HBIO) Other Working Capital Changes (2010 - 2026)
Harvard Bioscience (HBIO) reported Other Working Capital Changes of $392000.0 for Q1 2026, up 504.12% year-over-year from $64887.4 in Q1 2025, and up 135.64% quarter-over-quarter from -$1.1 million in Q4 2025.
Harvard Bioscience (HBIO) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Other Working Capital Changes data on file, last reported at $392000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $392000.0, up 504.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 51.99% YoY), and the FY2025 annual result was -$1.5 million, down 116.67% from the prior year.
- Other Working Capital Changes grew to $392000.0 in Q1 2026 per HBIO's latest filing, from -$1.1 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.4 million in Q3 2022 and troughed at -$1.7 million in Q3 2024.
- A 5-year average of -$68647.1 and a median of $137000.0 in 2023 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 581.02% in 2024 and fell as far as 987.37% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$1.3 million in 2022, then surged by 139.14% to $503000.0 in 2023, then slumped by 66.0% to $171000.0 in 2024, then plunged by 743.27% to -$1.1 million in 2025, then jumped by 135.64% to $392000.0 in 2026.
- Business Quant data shows HBIO's Other Working Capital Changes at $392000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$16000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Jun 30, 2025 | -308,000.00 |
| Jun 30, 2025 | -308,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | -1.69 Mn |
| Sep 30, 2024 | -1.69 Mn |
| Jun 30, 2024 | 933,000.00 |
| Jun 30, 2024 | 933,000.00 |
| Mar 31, 2024 | -120,000.00 |
| Mar 31, 2024 | -120,000.00 |
| Dec 31, 2023 | 503,000.00 |
| Dec 31, 2023 | 503,000.00 |